EXACT Sciences Corporation (EXAS) Key Ratios
$104.91
$0.00 (0.00%)As on 23-Mar-2026 09:30EDT
Market cap
$20,026 Mln
Revenue (TTM)
$3,247 Mln
P/E Ratio
--
P/B Ratio
8.3
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 3.25 | 23.12 | 17.69 | 15.92 | 16.84 |
| EBIT | -862.34 | 91.16 | 82.40 | 19.59 | 12.23 |
| Net Profit | -338.68 | 90.06 | 79.79 | 18.75 | 12.54 |
| EPS | -337.58 | 90.29 | 80.14 | 19.06 | 12.47 |
| Book Value | -- | -- | -2.38 | -9.61 | -2.40 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Dec-25 | Dec-24 | Dec-23 |
| EBIT-Margin
| -15.51 | -24.63 | -3.05 | -36.40 | -7.09 |
| Net Margin
| -- | -31.65 | -- | -- | -- |
| Return on equity
| -17.45 | -18.58 | -8.66 | -37.09 | -6.60 |
| Return on Capital
| -8.91 | -9.87 | -4.13 | -18.95 | -3.65 |
| Return on Assets
| -7.78 | -8.65 | -3.53 | -16.60 | -3.22 |
| Debt to Equity (x)
| -- | -- | 1.05 | 1.15 | 0.81 |
Profitability
ROCE
-4.13
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
EXACT Sciences Corporation (EXAS)
|
-4.13
|
-18.95
|
-3.65
|
-11.07
|
-11.53
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-8.66
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
EXACT Sciences Corporation (EXAS)
|
-8.66
|
-37.09
|
-6.60
|
-19.39
|
-21.18
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
-3.53
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
EXACT Sciences Corporation (EXAS)
|
-3.53
|
-16.60
|
-3.22
|
-9.66
|
-10.26
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Margin
-3.05
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
EXACT Sciences Corporation (EXAS)
|
-3.05
|
-36.40
|
-7.09
|
-29.68
|
-46.95
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Margin
-6.40
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
EXACT Sciences Corporation (EXAS)
|
-6.40
|
-37.29
|
-8.17
|
-30.20
|
-33.11
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
0.18
--
Year on year growth in net sales
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
EXACT Sciences Corporation (EXAS)
|
0.18
|
0.10
|
0.20
|
0.18
|
0.18
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
90.13
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
EXACT Sciences Corporation (EXAS)
|
90.13
|
-466.30
|
71.34
|
25.43
|
-1.52
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
79.79
--
Year on year growth in profit after tax
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
EXACT Sciences Corporation (EXAS)
|
79.79
|
-403.97
|
67.26
|
-4.68
|
27.68
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EPS Growth
0.80
--
Year on year growth in earnings per share
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
EXACT Sciences Corporation (EXAS)
|
0.80
|
-3.93
|
0.68
|
-0.02
|
0.34
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
1.05
--
Total debt / Net worth
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
EXACT Sciences Corporation (EXAS)
|
1.05
|
1.15
|
0.81
|
0.80
|
0.70
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.02
--
(Short term borrowings / Net worth)
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
EXACT Sciences Corporation (EXAS)
|
0.02
|
0.12
|
0.03
|
0.01
|
0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.43
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
EXACT Sciences Corporation (EXAS)
|
2.43
|
2.15
|
2.32
|
2.38
|
2.76
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Quick Ratio
2.17
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
EXACT Sciences Corporation (EXAS)
|
2.17
|
1.92
|
2.07
|
2.09
|
2.56
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
-3.01
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
EXACT Sciences Corporation (EXAS)
|
-3.01
|
-31.41
|
-7.26
|
-44.49
|
-64.42
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
9.20
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
EXACT Sciences Corporation (EXAS)
|
9.20
|
9.02
|
8.15
|
7.58
|
12.26
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Asset Turnover
0.55
--
Sales / Average Total Assets
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
EXACT Sciences Corporation (EXAS)
|
0.55
|
0.44
|
0.39
|
0.32
|
0.30
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Receivable days
30.80
--
Average Debtors / Sales * 365
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
EXACT Sciences Corporation (EXAS)
|
30.80
|
29.96
|
26.42
|
32.83
|
46.49
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
60.97
--
Average Inventory / Sales * 365
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
EXACT Sciences Corporation (EXAS)
|
60.97
|
63.00
|
60.84
|
61.65
|
78.53
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
49.26
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
EXACT Sciences Corporation (EXAS)
|
49.26
|
36.60
|
38.06
|
39.42
|
41.22
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
42.52
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
EXACT Sciences Corporation (EXAS)
|
42.52
|
56.36
|
49.20
|
55.06
|
83.80
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
-92.67
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
EXACT Sciences Corporation (EXAS)
|
-92.67
|
-10.12
|
-65.68
|
-14.10
|
-22.53
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
8.03
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
EXACT Sciences Corporation (EXAS)
|
8.03
|
4.33
|
4.26
|
2.89
|
3.96
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
170.02
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
EXACT Sciences Corporation (EXAS)
|
170.02
|
-15.37
|
518.59
|
-25.19
|
-22.75
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|